Virginia Retirement Systems Et Al Revolution Medicines, Inc. Transaction History

Virginia Retirement Systems Et Al

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 22, 2023	SELL	$20.28 - $27.0 $158,184 - $210,600	-7,800 Reduced 41.71%	10,900 $291,000
Q1 2023 Jul 11, 2023	BUY	$20.76 - $30.09 $74,736 - $108,324	3,600 Added 23.84%	18,700 $405,000
Q4 2022 May 17, 2023	SELL	$17.68 - $25.53 $198,016 - $285,936	-11,200 Reduced 42.59%	15,100 $360 Million
Q3 2022 May 16, 2023	BUY	$17.46 - $26.0 $228,726 - $340,600	13,100 Added 99.24%	26,300 $519 Million
Q1 2022 Apr 21, 2022	BUY	$17.31 - $26.4 $228,491 - $348,480	13,200 New	13,200 $337,000

266

161M

260K

620K

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.8B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.